Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related ABT
Benzinga's Top Upgrades, Downgrades For August 17, 2017
Lightning Round: Jim Cramer Shares His Thoughts On Freeport-McMoRan, Pfizer And More
Related PCLN
Your Easy Guide To Credit Suisse's New Top Stocks List
Trivago's Tribulations Not Likely Negative For Priceline, Expedia

Analysts at Goldman Sachs upgraded Abbott Laboratories (NYSE: ABT) from “neutral” to “buy.” The target price for Abbott Laboratories has been raised from $38 to $44. Abbott's stock closed at $36.59 on Friday.

Deutsche Bank upgraded priceline.com (NASDAQ: PCLN) from “hold” to “buy.” The target price for priceline.com has been raised from $715 to $900. priceline.com's shares closed at $813.66 on Friday.

Analysts at Maxim Group upgraded J.C. Penney Company (NYSE: JCP) from “hold” to “buy.” The target price for J.C. Penney has been raised from $16.50 to $27. J.C. Penney's shares closed at $18.01 on Friday.

Morgan Stanley upgraded E-Commerce China Dangdang (NYSE: DANG) from “equal-weight” to “overweight.” The target price for E-Commerce China Dangdang has been raised from $5 to $6.50. E-Commerce China Dangdang's shares closed at $5.71 on Friday.

Latest Ratings for ABT

DateFirmActionFromTo
Aug 2017CitigroupInitiates Coverage OnNeutral
Jul 2017ArgusMaintainsBuy
Jul 2017Deutsche BankMaintainsBuy

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ABT + DANG)

View Comments and Join the Discussion!
Loading...
Loading...